Food & Drug Adminstration, n.d.)
[1] [2] Las directrices de la American Diabetes Association (ADA) establecen que los agonistas GLP-1 constituyen una terapia crnica para el manejo de la diabetes tipo 2
However, upon closer inspection, there are numerous red flags that suggest the Oyikey GLP-1 patch may not be as legitimate or effective as it claims to be: Unrealistic and potentially dangerous claims of extremely fast weight loss Losing 16+ kg (over 35 pounds) in just 8 weeks, as the Oyikey website states, is an unrealistic and unhealthy rate of weight loss
Song EK, Wu JR
There are no FDA-approved generic versions of semaglutide, and the FDA has issued warnings about compounded semaglutide products that may contain impurities, incorrect dosages, or different substances than labeled
Stress and anxiety delay epidermal barrier recovery, impair skin immune function, increase inflammation and oxidative stress